JP Morgan Cuts Qiagen (QGEN) Price Target to $52
Key Points
- JP Morgan lowered its rating on Qiagen N.V. to Neutral on October 22, 2026, while cutting its price target from $55.00 to $52.00.
- JP Morgan's $52 price target implies 4% upside from Qiagen N.V.'s ($QGEN) current $50 share price.
- The stock recently traded near $50.00, sitting below the firm's new target price but above its 50-day moving average of $44.14.
- Wall Street maintains 12 analyst opinions on the healthcare firm, which reports its next earnings on November 4, 2026.
Get Qiagen N.V. text alerts
We text you when insiders, Congress, analysts or big funds move on $QGEN.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Qiagen N.V. alert may contain errors. Disclosures
JP Morgan lowered its rating on Qiagen N.V. (NYSE:QGEN) to Neutral on October 22, 2026, while reducing its price target from $55.00 to $52.00. The research note was issued on the same day the stock closed at $50.28.
QGEN
Qiagen N.V.
JP Morgan vs. the S&P 500
Hypothetical returns from JP Morgan's disclosed trades, not real profit or advice. How we model this.
JP Morgan's Call on Qiagen
In its October 22 update, JP Morgan adjusted its stance on the diagnostics and research firm by moving the rating to Neutral and trimming the price target down to $52.00 from $55.00. Earlier in the month on October 14, the same firm had maintained an Overweight rating with a $55.00 target.
Other Institutional Activity in Qiagen
Principal Financial Group, Inc. grew its holdings by 6,643,158 shares, ending with 6,648,681 shares worth about $334,328,923. Earnest Partners LLC grew its holdings by 704,858 shares, ending with 4,573,455 shares worth about $229,976,183. Millennium Management Llc grew its holdings by 3,247,765 shares, ending with 3,845,605 shares worth about $193,376,246.
Qiagen N.V. Stock Holds Steady
Qiagen shares recently traded around $50.00 as of October 22, 2026. On the day of the rating change, the stock closed at $50.28. The shares trade above both their 50-day moving average of $44.14 and their 200-day moving average of $42.50.
$QGEN price target
Qiagen N.V. daily closes and this analyst's $52 target. Not advice.
Recent Earnings
Qiagen reported trailing twelve-month revenue of $2,100,363,008 alongside earnings of $1.97 per share. The company posts a return on equity of 11.9% and a net margin of 19.5%. Its next earnings report is scheduled for November 4, 2026.
Dividend
Qiagen pays an annual dividend rate of $0.35 per share, yielding 0.7% with a payout ratio of 17.8%.
Analysts Set New Price Targets
On September 9, 2026, UBS maintained a Neutral rating while lowering its target from $52.00 to $47.00. On October 6, 2026, Barclays upgraded the stock to Overweight and raised its target from $40.00 to $55.00. Baird maintained an Outperform rating on October 22, 2026, moving its target from $50.00 to $52.00. Across Wall Street, analysts hold a mean price target of $48.64 based on 12 opinions.
About Qiagen
Headquartered in Venlo, Netherlands, Qiagen provides sample-to-insight solutions that transform biological samples into molecular insights for customers worldwide. The healthcare company operates within the diagnostics and research industry.
Bottom Line
Investors will look toward Qiagen's upcoming earnings release on November 4, 2026, for fresh details on financial performance. Market participants continue to weigh shifting analyst views as shares trade near the $50.00 level.
Related Filing Alerts
Source: JP Morgan's rating change on $QGEN (Oct 22, 2026). Written by software, not financial advice. How we make alerts